Memantin Aaa-Pharma (Memantine Hydrochloride)

Memantine acts as a non‑competitive antagonist of the NMDA receptor. By blocking excessive calcium entry through the receptor’s ion channel, it reduces glutamate‑induced excitotoxicity, helping to protect neurons and preserve cognitive function.

The dosage of Memantin Aaa-Pharma is determined by the prescribing clinician based on the patient’s condition, renal function, and tolerability. The prescriber will set the appropriate dose and titration schedule.

Safety data for memantine in pregnancy and lactation are limited. The product should only be used if the potential benefit justifies the potential risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.

To request Memantin Aaa-Pharma, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Memantin belongs to the NMDA receptor antagonist class, whereas many other Alzheimer’s agents are acetylcholinesterase inhibitors (e.g., donepezil). Memantine targets excitotoxic pathways rather than cholinergic deficiency, and it is often used when disease has progressed to moderate‑severe stages or in combination with an acetylcholinesterase inhibitor.

Memantin Aaa-Pharma should be stored at room temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and do not use after the expiry date.

The medication is taken orally, usually once daily after a gradual titration period as directed by the prescriber. Tablets should be swallowed whole with water and not crushed or chewed unless otherwise instructed.

Serious adverse events, although uncommon, include seizures, severe allergic reactions, hallucinations or psychosis, cardiac arrhythmias, and liver injury. Patients should be monitored closely for any new or worsening neurological or hepatic symptoms.

Memantin Aaa-Pharma is contraindicated in patients with known hypersensitivity to memantine or any of its excipients. Caution is advised for individuals with severe renal impairment, uncontrolled hypertension, or a history of seizures, and the drug should be avoided in those situations unless a specialist determines otherwise.